€1.41
2.08% yesterday
Xetra, Jul 01, 05:36 pm CET
ISIN
DE0006044001
Symbol
MAK
Index

MATERNUS-Kliniken Stock price

€1.41
-0.15 9.62% 1M
+0.05 3.68% 6M
+0.05 3.68% YTD
-0.45 24.19% 1Y
-1.49 51.38% 3Y
-0.97 40.76% 5Y
+0.04 2.55% 10Y
-0.59 29.50% 20Y
Xetra, Closing price Tue, Jul 01 2025
-0.03 2.08%
ISIN
DE0006044001
Symbol
MAK
Index
Sector

Key metrics

Basic
Market capitalization
€30.4m
Enterprise Value
€207.3m
Net debt
€176.9m
Cash
€9.6m
Shares outstanding
21.0m
Valuation (TTM | estimate)
P/E
negative | -
P/S
0.19 | -
EV/Sales
1.30 | -
EV/FCF
15.78
P/B
negative
Dividends
DPS
Yield 1Y | 5Y
- | -
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
- | -
Increased
-
Financials (TTM | estimate)
Revenue
€159.4m | -
EBITDA
€11.5m | -
EBIT
€-3.1m
Net Income
€-16.1m | -
Free Cash Flow
€13.1m
Growth (TTM | estimate)
Revenue
1.28% | -
EBITDA
1,645.45% | -
EBIT
79.05%
Net Income
30.90% | -
Free Cash Flow
763.64%
Margin (TTM | estimate)
Gross
86.41%
EBITDA
7.22% | -
EBIT
-1.96%
Net
-10.10% | -
Free Cash Flow
8.24%
Financial Health
Equity Ratio
-34.82%
Return on Equity
26.52%
ROCE
-4.22%
ROIC
-2.86%
Debt/Equity
-3.35
More
EPS
€-0.77
FCF per Share
€0.63
Short interest
-
Employees
1.45k
Rev per Employee
€70.00k
Show more

Is MATERNUS-Kliniken a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,951 stocks worldwide.

MATERNUS-Kliniken Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a MATERNUS-Kliniken forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a MATERNUS-Kliniken forecast:

Hold
43%
Sell
57%

Financial data from MATERNUS-Kliniken

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
159 159
1% 1%
100%
- Direct Costs 22 22
17% 17%
14%
138 138
5% 5%
86%
- Selling and Administrative Expenses 113 113
4% 4%
71%
- Research and Development Expense - -
-
-
12 12
1,645% 1,645%
7%
- Depreciation and Amortization 15 15
6% 6%
9%
EBIT (Operating Income) EBIT -3.13 -3.13
79% 79%
-2%
Net Profit -16 -16
31% 31%
-10%

In millions EUR.

Don't miss a Thing! We will send you all news about MATERNUS-Kliniken directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MATERNUS-Kliniken Stock News

Company Profile

Maternus-Kliniken AG engages in the operation of senior housing facilities, nursing homes, and rehabilitation centers. It operates through the following segments: Rehabilitation, Senior Retirement Homes and Nursing Care Facilities, and Maternus AG. The Rehabilitation segment comprises follow-up treatment and rehabilitation measures in the indication areas orthopedics, behavioral orthopedics, cardiology, internal medicine, metabolic disorders, and neurology. The Senior Retirement Homes and Nursing Care Facilities segment specializes in full-station services care, short-term care, and assisted living. The Maternus AG segment provides primarily intersegmentary services. The company was founded in 1877 and is headquartered in Berlin, Germany.

Head office Germany
CEO Mario Ruano-Wohlers
Employees 1,452
Founded 1877
Website www.maternus.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today